Experiments in dogs, rabbits and monkeys show the efficacy and biocompatibility of a new MRI/MRA contrast agent in detecting stroke. This T1 MRI contrast agent based on ultrasmall iron oxide nanoparticles could become a possible alternative to clinically used gadolinium-based agents.
from Top Technology News -- ScienceDaily http://ift.tt/2ueqe4P
via IFTTT
Technology and Professional News
IFTTT
Top Technology News -- ScienceDaily
New MRI contrast agent tested on big animals
Next
« Prev Post
« Prev Post
Previous
Next Post »
Next Post »
Subscribe to:
Post Comments (Atom)
EmoticonEmoticon